drugset / Trial / NCT04021706
Effect of a Ghrelin Receptor Agonist on Muscle and Bone
Phase 1
Completed
32 enrolled
Tufts University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Adults with low muscle mass also usually have low bone mass, making them vulnerable to falls, fractures and other injuries. This project will determine the effectiveness of treatment with a ghrelin receptor agonist in improving short term indicators of muscle and bone health in adults with low bone and muscle mass. The results of this trial will inform the design of a larger, definitive randomized trial designed to establish efficacy.
Timeline
- Start
- 2019-12-05
- Primary completion
- 2023-01-26
- Completion
- 2023-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Anamorelin | Small molecule | 100 mg | Oral |